SCHEMBL5452087

SCHEMBL5452087

BrCCCN=Cc1ccc2c(c1)OCO2

nearest known ligand 0.62

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 6/20 0.62
KDM4E B2RXH2 4/20 0.62
ALOX15 P16050 1/20 0.62
HSD17B10 Q99714 2/20 0.48
TP53 P04637 1/20 0.48
GRIN2D O15399 1/20 0.48
GRIN3B O60391 1/20 0.48
GRIN1 Q05586 1/20 0.48
GRIN2A Q12879 1/20 0.48
GRIN2B Q13224 1/20 0.48
GRIN2C Q14957 1/20 0.48
GRIN3A Q8TCU5 1/20 0.48
TDP1 Q9NUW8 1/20 0.47
CYP3A4 P08684 3/20 0.47
CYP1A2 P05177 2/20 0.47
CYP2D6 P10635 2/20 0.47
CYP2C9 P11712 2/20 0.47
CYP2C19 P33261 1/20 0.47
GSK3A P49840 2/20 0.46
GSK3B P49841 2/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14627221 1.00 ALDH1A1 (0.62) ALDH1A1KDM4EALOX15HSD17B10TP53
SCHEMBL4454927 0.85 ALDH1A1 (0.62) ALDH1A1KDM4EALOX15HSD17B10TP53
SCHEMBL4454930 0.85 ALDH1A1 (0.62) ALDH1A1KDM4EALOX15HSD17B10TP53
SCHEMBL16704292 0.81 ALDH1A1 (0.58) ALDH1A1KDM4EALOX15HSD17B10TP53
SCHEMBL3031855 0.81 ALDH1A1 (0.58) ALDH1A1KDM4EALOX15HSD17B10TP53
SCHEMBL11558188 0.81 ALDH1A1 (0.58) ALDH1A1KDM4EALOX15HSD17B10TP53
SCHEMBL11558191 0.81 ALDH1A1 (0.58) ALDH1A1KDM4EALOX15HSD17B10TP53
SCHEMBL16168568 0.79 ALDH1A1 (0.55) ALDH1A1KDM4EALOX15HSD17B10TP53
SCHEMBL4449591 0.78 CYP3A4 (0.54) ALDH1A1KDM4EALOX15HSD17B10TP53
SCHEMBL4449592 0.78 CYP3A4 (0.54) ALDH1A1KDM4EALOX15HSD17B10TP53

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20160367685-A1 DUPA-INDENOISOQUINOLINE CONJUGATES NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT 2016-12-22 US disclosed
US-20070015751-A1 Nitro and amino substituted heterocycles as topoisomerase I targeting agents RUTGERS, THE STATE UNIVERSITY OF NEW JERSEY 2007-01-18 US disclosed
US-6992088-B2 Nitro and amino substituted heterocycles as topoisomerase I targeting agents RUTGERS, THE STATE UNIVERSITY OF NEW JERSEY (US) 2006-01-31 US disclosed
US-20040110782-A1 Nitro and amino substituted heterocycles as topoisomerase I targeting agents RUTGERS, THE STATE UNIVERSITY OF NEW JERSEY 2004-06-10 US disclosed
WO-2004014862-A1 NITRO AND AMINO SUBSTITUTED HETEROCYCLES AS TOPOISOMERASE I TARGETING AGENTS RUTGERS, THE STATE UNIVERSITY (US) 2004-02-19 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070015751-A1 Nitro and amino substituted heterocycles as topoisomerase I targeting agents TOP1, TOP2A, TOP2B ALDH1A1 1232/4885KDM4E 1439/4885ALOX15 3718/4885
US-20040110782-A1 Nitro and amino substituted heterocycles as topoisomerase I targeting agents TOP1, TOP2A, TOP2B ALDH1A1 902/4885KDM4E 1481/4885ALOX15 3370/4885
US-20160367685-A1 DUPA-INDENOISOQUINOLINE CONJUGATES PDS5B, KLK3, PDS5A ALDH1A1 205/4885KDM4E 2688/4885ALOX15 4269/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.